CVS Health Corp.

Drug and biologic product-related enforcement is expected to remain strong during the next Trump Administration, although the focus could shift compared to the Biden Administration. Imported ingredien

Because the Inflation Reduction Act (IRA) is making significant changes to the Medicare Part D benefit structure next year, industry watchers have been bracing for US Centers for Medicare and Medicaid

When the Federal Trade Commission (FTC) officially accused the three largest PBMs of artificially inflating insulin prices, it marked the latest move in what has become a protracted effort by federa

Alternatives to the top pharmacy benefits managers say they have fairer and more cost-effective business models for administering employers’ drug benefits, but the vertical integration and power of th